Puri Raj K.
Transaction: 06/16/2026
BUY
Change
+15,000
Price
Not reported
Filing
06/18/2026
Type
BUY
Iovance Biotherapeutics, Inc.
IOVA • Biotechnology
$8.79
▲ +0.09 (+1.03%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$3.96B
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Positive revenue growth · 1107.6%Manageable debt level · 0.07Healthy liquidity · 3.2Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$8.79
Change1.03%
Shares Out450.19M
Market Cap$3.96B
Enterprise Value$3.66B
52W Range1.66 - 5.63
Beta0.70
P/E-13.67
P/S12.18
P/B5.38
P/FCF-13.35
EV/Sales11.26
Price$8.79
Change1.03%
Shares Out450.19M
Market Cap$3.96B
Enterprise Value$3.66B
52W Range1.66 - 5.63
Beta0.70
P/E-13.67
P/S12.18
P/B5.38
P/FCF-13.35
EV/Sales11.26
EV/EBITDA-13.85
EV/FCF-12.35
Earnings Yield-7.32%
FCF Yield-7.49%
Dividend Yield0.00%
Gross Margin97.23%
Oper. Margin-153.08%
Profit Margin-148.38%
Debt/Eq0.07
Current Ratio3.20
Quick Ratio2.83
Target$7.83
Target Upside-10.92%
Target Median$6.50
Target Range5.00 - 13.00
Volume17.40M
Avg Volume14.09M
EPS Surprise0.00
Investment DNA
How strong this company looks for long-term investors
53
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
82/100
Why this score▼
Positive revenue growth · 1107.6%Manageable debt level · 0.07Healthy liquidity · 3.2Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 21 analyst votes · 2026-09-05
88/100
Bullish
Bullish
16
Hold
5
Bearish
0
Price Target
2026-08-07
Low
$5.00
Mean
$7.67
Median
$5.00
High
$13.00
Insider Transactions
Recent executive and insider activity
Maynard Ryan D
Transaction: 06/16/2026
BUY
Change
+90,316
Price
Not reported
Filing
06/18/2026
Type
BUY
Countouriotis Athena
Transaction: 06/16/2026
BUY
Change
+90,316
Price
Not reported
Filing
06/18/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Puri Raj K. | BUY | +15,000 | Not reported | 06/16/2026 | 06/18/2026 |
| Maynard Ryan D | BUY | +90,316 | Not reported | 06/16/2026 | 06/18/2026 |
| Countouriotis Athena | BUY | +90,316 | Not reported | 06/16/2026 | 06/18/2026 |
| Dukes Iain D. | BUY | +180,632 | Not reported | 06/16/2026 | 06/18/2026 |
| WEISER MICHAEL | BUY | +90,316 | Not reported | 06/16/2026 | 06/18/2026 |
| BILINSKY IGOR | SELL | -7,813 | Not reported | 06/05/2026 | 06/09/2026 |
| BILINSKY IGOR | SELL | -3,976 | $4.23 | 06/05/2026 | 06/09/2026 |
| Puri Raj K. | SELL | -9,766 | Not reported | 06/05/2026 | 06/09/2026 |
| Puri Raj K. | SELL | -3,843 | $4.23 | 06/05/2026 | 06/09/2026 |
| GRAF FINCKENSTEIN FRIEDRICH | SELL | -7,813 | Not reported | 06/05/2026 | 06/09/2026 |
| GRAF FINCKENSTEIN FRIEDRICH | SELL | -3,976 | $4.23 | 06/05/2026 | 06/09/2026 |
| Vogt Frederick G | SELL | -15,625 | Not reported | 06/05/2026 | 06/09/2026 |
| Vogt Frederick G | SELL | -6,638 | $4.23 | 06/05/2026 | 06/09/2026 |
| BILINSKY IGOR | SELL | -8,790 | Not reported | 06/01/2026 | 06/03/2026 |
| BILINSKY IGOR | SELL | -4,473 | $3.96 | 06/01/2026 | 06/03/2026 |
| GRAF FINCKENSTEIN FRIEDRICH | SELL | -8,790 | Not reported | 06/01/2026 | 06/03/2026 |
| GRAF FINCKENSTEIN FRIEDRICH | SELL | -4,473 | $3.96 | 06/01/2026 | 06/03/2026 |
| Puri Raj K. | SELL | -5,469 | Not reported | 06/01/2026 | 06/03/2026 |
| Puri Raj K. | SELL | -2,508 | $3.96 | 06/01/2026 | 06/03/2026 |
| Vogt Frederick G | SELL | -41,668 | Not reported | 06/01/2026 | 06/03/2026 |